Tipranavir in the Protease Inhibitors Arena

por Vergani, Barbara, Rusconi, Stefano
Publicado 2012

A push for 90-90-90: Initial treatment with INSTI-based regimens against HIV-1 infection

por Rusconi, Stefano, Giacomelli, Andrea
Publicado 2019

COVID-19: studying the global pandemic – foreword

por Rusconi, Stefano, Hayden, Frederick G
Publicado 2020

Dolutegravir plus lamivudine for hiv treatment: Does the historical genotype really matter?

por Giacomelli, Andrea, Conti, Federico, Rusconi, Stefano
Publicado 2020

HIV and COVID-19 pandemic collision: turning challenges into opportunity

por Rusconi, Stefano, Pezzati, Laura, Formenti, Tiziana, Giacomelli, Andrea
Publicado 2021

Kinetics of CD169, HLA-DR, and CD64 expression as predictive biomarkers of SARS-CoV2 outcome

por Gatti, Arianna, Fassini, Paola, Mazzone, Antonino, Rusconi, Stefano, Brando, Bruno, Mistraletti, Giovanni
Publicado 2023

Efficacy and safety of a dual boosted protease inhibitor-based regimen, atazanavir and fosamprenavir/ritonavir, against HIV: experience in a pediatric population

por Rusconi, Stefano, Giacomet, Vania, Mameli, Chiara, Viganò, Alessandra, Viganò, Ottavia, Adorni, Fulvio, Galli, Massimo, Zuccotti, Gian Vincenzo
Publicado 2012

Durability of INI-containing regimens after switching from PI-containing regimens: a single-centre cohort of drug-experienced HIV-infected subjects

por Giacomelli, Andrea, Ranzani, Alice, Oreni, Letizia, Gervasi, Elena, Lupo, Angelica, Ridolfo, Anna Lisa, Galli, Massimo, Rusconi, Stefano
Publicado 2019

Factors involved in treatment durability and immunological recovery in a cohort of HIV-positive patients receiving atazanavir-based regimens

por Giacomelli, Andrea, Oreni, Letizia, Franzetti, Marco, Di Cristo, Valentina, Vergani, Barbara, Morosi, Manuela, Colella, Elisa, Galli, Massimo, Rusconi, Stefano
Publicado 2014

Invasive and Non-Invasive Human Salmonellosis Cases Admitted between 2015 and 2021 in Four Suburban Hospitals in the Metropolitan Area of Milan (Italy): A Multi-Center Retrospectiv...

por Pagani, Gabriele, Parenti, Marco, Franzetti, Marco, Pezzati, Laura, Bassani, Francesco, Osnaghi, Bianca, Vismara, Laura, Pavia, Claudia, Mirri, Paola, Rusconi, Stefano
Publicado 2023

Shall We Dance? Extending TANGO’s Results to Clinical Practice

por Borghetti, Alberto, Ciccullo, Arturo, Baldin, Gianmaria, Rusconi, Stefano, Capetti, Amedeo, Sterrantino, Gaetana, Gennari, William, Mussini, Cristina, Borghi, Vanni, Di Giambenedetto, Simona
Publicado 2020

Nucleoside Reverse-Transcriptase Inhibitor Resistance Mutations Predict Virological Failure in Human Immunodeficiency Virus-Positive Patients During Lamivudine Plus Dolutegravir Ma...

por Borghetti, Alberto, Giacomelli, Andrea, Borghi, Vanni, Ciccullo, Arturo, Dusina, Alex, Fabbiani, Massimiliano, Rusconi, Stefano, Zazzi, Maurizio, Mussini, Cristina, Di Giambenedetto, Simona
Publicado 2021

Darunavir does not prevent SARS-CoV-2 infection in HIV patients

por Riva, Agostino, Conti, Federico, Bernacchia, Dario, Pezzati, Laura, Sollima, Salvatore, Merli, Stefania, Siano, Matteo, Lupo, Angelica, Rusconi, Stefano, Cattaneo, Dario, Gervasoni, Cristina
Publicado 2020

Impact of switching to TAF/FTC/RPV, TAF/FTC/EVG/cobi and ABC/3TC/DTG on cardiovascular risk and lipid profile in people living with HIV: a retrospective cohort study

por Giacomelli, Andrea, Conti, Federico, Pezzati, Laura, Oreni, Letizia, Ridolfo, Anna Lisa, Morena, Valentina, Bonazzetti, Cecilia, Pagani, Gabriele, Formenti, Tiziana, Galli, Massimo, Rusconi, Stefano
Publicado 2021

Differences in the Prevalence of SARS-CoV-2 Infection and Access to Care between Italians and Non-Italians in a Social-Housing Neighbourhood of Milan, Italy

por Pagani, Gabriele, Conti, Federico, Giacomelli, Andrea, Oreni, Letizia, Beltrami, Martina, Pezzati, Laura, Casalini, Giacomo, Rondanin, Rossana, Prina, Andrea, Zagari, Antonino, Rusconi, Stefano, Galli, Massimo
Publicado 2021

Cardiovascular risk and dyslipidemia among persons living with HIV: a review

por Maggi, Paolo, Di Biagio, Antonio, Rusconi, Stefano, Cicalini, Stefania, D’Abbraccio, Maurizio, d’Ettorre, Gabriella, Martinelli, Canio, Nunnari, Giuseppe, Sighinolfi, Laura, Spagnuolo, Vincenzo, Squillace, Nicola
Publicado 2017

Proportion and factors associated with recent HIV infection in a cohort of patients seen for care in Italy over 1996-2014: Data from the ICONA Foundation Study cohort

por Nozza, Silvia, Cozzi-Lepri, Alessandro, Bai, Francesca, Rusconi, Stefano, Gori, Andrea, Cinque, Paola, Ammassari, Adriana, Caramello, Pietro, Tambussi, Giuseppe, D’Arminio Monforte, Antonella, Marchetti, Giulia
Publicado 2017

Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: an observational cohort study

por Mussini, Cristina, Lorenzini, Patrizia, Cozzi-Lepri, Alessandro, Marchetti, Giulia, Rusconi, Stefano, Gori, Andrea, Nozza, Silvia, Lichtner, Miriam, Antinori, Andrea, Cossarizza, Andrea, d’Arminio Monforte, Antonella
Publicado 2018

Safety and therapeutic efficacy of the switch to maraviroc+darunavir/ritonavir in HIV/HCV coinfected patients: initial results from GUSTA study

por Gagliardini, Roberta, Rossetti, Barbara, Bianco, Claudia, Rusconi, Stefano, Colafigli, Manuela, Prinapori, Roberta, Francisci, Daniela, Fantauzzi, Alessandra, Orofino, Giancarlo, Vignale, Francesca, Di Giambenedetto, Simona, De Luca, Andrea
Publicado 2014

Effectiveness, durability, and safety of darunavir/ritonavir in HIV-1-infected patients in routine clinical practice in Italy: a postauthorization noninterventional study

por Antinori, Andrea, Meraviglia, Paola, Monforte, Antonella d’Arminio, Castagna, Antonella, Mussini, Cristina, Bini, Teresa, Gianotti, Nicola, Rusconi, Stefano, Colella, Elisa, Airoldi, Giuseppe, Mancusi, Daniela, Termini, Roberta
Publicado 2016